A detailed history of Sg Americas Securities, LLC transactions in Siga Technologies Inc stock. As of the latest transaction made, Sg Americas Securities, LLC holds 21,167 shares of SIGA stock, worth $127,002. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,167
Holding current value
$127,002
% of portfolio
0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

BUY
$6.74 - $11.97 $142,665 - $253,368
21,167 New
21,167 $143,000
Q1 2023

Apr 28, 2023

SELL
$5.23 - $8.42 $101,728 - $163,777
-19,451 Reduced 54.76%
16,067 $92,000
Q4 2022

Feb 02, 2023

SELL
$7.29 - $10.14 $272,004 - $378,343
-37,312 Reduced 51.23%
35,518 $261,000
Q3 2022

Oct 31, 2022

BUY
$10.02 - $26.15 $586,751 - $1.53 Million
58,558 Added 410.3%
72,830 $750,000
Q2 2022

Jul 29, 2022

BUY
$6.5 - $13.68 $92,768 - $195,240
14,272 New
14,272 $165,000
Q1 2022

Apr 29, 2022

SELL
$5.96 - $7.61 $108,615 - $138,684
-18,224 Closed
0 $0
Q4 2021

Feb 07, 2022

SELL
$6.96 - $9.26 $110,079 - $146,456
-15,816 Reduced 46.46%
18,224 $137,000
Q3 2021

Nov 01, 2021

BUY
$5.71 - $7.39 $194,368 - $251,555
34,040 New
34,040 $252,000
Q2 2021

Aug 12, 2021

SELL
$6.1 - $7.58 $65,867 - $81,848
-10,798 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$6.3 - $7.71 $68,027 - $83,252
10,798 New
10,798 $70,000
Q3 2020

Nov 09, 2020

SELL
$5.62 - $7.68 $176,951 - $241,812
-31,486 Closed
0 $0
Q2 2020

Jul 20, 2020

BUY
$4.55 - $6.19 $46,396 - $63,119
10,197 Added 47.9%
31,486 $186,000
Q1 2020

Apr 30, 2020

BUY
$3.99 - $5.46 $38,722 - $52,989
9,705 Added 83.78%
21,289 $102,000
Q4 2019

Jan 28, 2020

BUY
$4.34 - $5.86 $50,274 - $67,882
11,584 New
11,584 $55,000

Others Institutions Holding SIGA

About SIGA TECHNOLOGIES INC


  • Ticker SIGA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 73,024,096
  • Market Cap $438M
  • Description
  • SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla T...
More about SIGA
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.